Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06761066 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

StatusEnrolling by Invitation
PhaseNot applicable
Started2026-01-20
View on ClinicalTrials.gov ↗
The purpose of this clinical trial is to exploratively evaluate the efficacy and safety of NVP -NK4146 in improving mild cognitive impairment (MCI) in patients with due to Alzheimer's disease (AD) compared to placebo

Amendment history 3 changes detected by DataLookout

2026-09-02
notable
Enrolling by invitation only
2026-09-02
critical
Primary completion pushed: 2026-03-31 → 2027-09-30
2026-09-02
minor
Completion pushed: 2026-04-30 → 2027-12-30
Trial Details
NCT Number NCT06761066
Lead Sponsor NVP Healthcare
Conditions Alzheimer Disease
Enrollment 60 participants
Start Date 2026-01-20
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-01